<i>KRAS</i>,<i>NRAS</i>and<i>BRAF</i>mutations in Greek and Romanian patients with colorectal cancer: a cohort study
Șerban Negru(West University of Timişoara), George Nasioulas(Athens Medical Center), Eirini Papadopoulou(Athens Medical Center), Eliade Ciuleanu(Institute of Oncology Prof. Dr. Ion Chiricuta), Nikolaos Pavlidis(Democritus University of Thrace), Dana Lucia Stănculeanu(Institutul Oncologic Bucuresti), Gerasimos Aravantinos(Hospital Agioi Anargyroi), Angela Apessos, Haralabos P. Kalofonos(University of Patras), Nikolaos Touroutoglou(Interbalkan Medical Center), Constantin Volovăț(Institutul Regional de Oncologie), Adina Croitoru(Institutul Clinic Fundeni), Elias Athanasiadis(Mitera Hospital), Stylianos Kakolyris(University Hospital of Alexandroupolis), Nikolaos Ziras(Metaxa Hospital)
Cited by 43
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|838
Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes
|The American Journal of Human Genetics|1998|525
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
|Cancer Management and Research|2014|276
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2010|166